Lifitegrast 5% Ophthalmic Solution
Lifitegrast 5% Ophthalmic Solution is a pharmaceutical drug with 8 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
62.5%
5 of 8 finished
37.5%
3 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra
Clinical Trials (8)
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra
Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease
The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study
Effect of Lifitegrast 5% on Tear Film Markers
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8